USANA HEALTH SCIENCES INC·4

Feb 23, 6:18 PM ET

IIEKKING G DOUG 4

4 · USANA HEALTH SCIENCES INC · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

USANA CFO Doug Iieking Receives 41,639 RSU Award

What Happened

  • Doug Iieking, Chief Financial Officer of USANA Health Sciences (USNA), received a grant of 41,639 restricted stock units (RSUs) on February 19, 2026. The award was reported as a derivative award with no cash paid (reported price $0.00). This is a compensation grant (code A), not a market purchase or sale.

Key Details

  • Transaction date: 2026-02-19; Filing date: 2026-02-23 (filed with the SEC; appears to be within the required reporting window).
  • Award: 41,639 RSUs; reported acquisition price: $0.00.
  • Shares owned after transaction: not disclosed in the provided filing details.
  • Footnotes:
    • F1: Each RSU represents a contingent right to receive one share of USNA common stock upon vesting.
    • F2: The RSUs vest 25% on each February 19 thereafter (i.e., scheduled to vest in four annual installments).

Context

  • RSUs are a form of equity compensation that convert to shares only as they vest; they do not represent immediate buying or selling of shares. Such grants are common for executive compensation and do not by themselves indicate a buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-02-19
IIEKKING G DOUG
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-02-19+41,63983,218 total
    Common Stock (41,639 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  • [F2]On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.
Signature
/s/ Joshua Foukas, Attorney-in-Fact|2026-02-23

Documents

1 file
  • 4
    wk-form4_1771888724.xmlPrimary

    FORM 4